A DNA-PK phosphorylation site on MET regulates its signaling interface with the DNA damage response

被引:3
作者
Koch, Jonas P. [1 ,2 ,3 ,4 ]
Roth, Selina M. [2 ]
Quintin, Aurelie [1 ,2 ,3 ]
Gavini, Jacopo [2 ,4 ,5 ]
Orlando, Eleonora [1 ,2 ,3 ,4 ]
Riedo, Rahel [1 ,2 ,3 ]
Pozzato, Chiara [1 ,2 ,3 ]
Hayrapetyan, Liana [1 ,2 ,3 ,4 ]
Aebersold, Ruedi [6 ,7 ]
Stroka, Deborah M. M. [2 ,5 ]
Aebersold, Daniel M. M. [2 ]
Medo, Matus [1 ,2 ,3 ]
Zimmer, Yitzhak [1 ,2 ,3 ]
Medova, Michaela [1 ,2 ,3 ]
机构
[1] Bern Univ Hosp, Dept Biomed Res, Radiat Oncol, Inselspital, Bern, Switzerland
[2] Univ Bern, Bern, Switzerland
[3] Bern Univ Hosp, Dept Radiat Oncol, Inselspital, Freiburgstr 8, CH-3008 Bern, Switzerland
[4] Univ Bern, Grad Sch Cellular & Biomed Sci, CH-3010 Bern, Switzerland
[5] Bern Univ Hosp, Inselspital, Dept Biomed Res, Visceral Surg, Bern, Switzerland
[6] Swiss Fed Inst Technol, Inst Mol Syst Biol, Dept Biol, CH-8093 Zurich, Switzerland
[7] Univ Zurich, Fac Sci, CH-8057 Zurich, Switzerland
基金
瑞士国家科学基金会;
关键词
DEPENDENT PROTEIN-KINASE; GROWTH-FACTOR RECEPTOR; PRECLINICAL EVALUATION; TYROSINE KINASE; INVASIVE-GROWTH; INHIBITOR; CELLS; MECHANISM; CANCER; REPAIR;
D O I
10.1038/s41388-023-02714-6
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The DNA damage response (DDR) is intertwined with signaling pathways downstream of oncogenic receptor tyrosine kinases (RTKs). To drive research into the application of targeted therapies as radiosensitizers, a better understanding of this molecular crosstalk is necessary. We present here the characterization of a previously unreported MET RTK phosphosite, Serine 1016 (S1016) that represents a potential DDR-MET interface. MET S1016 phosphorylation increases in response to irradiation and is mainly targeted by DNA-dependent protein kinase (DNA-PK). Phosphoproteomics unveils an impact of the S1016A substitution on the overall long-term cell cycle regulation following DNA damage. Accordingly, the abrogation of this phosphosite strongly perturbs the phosphorylation of proteins involved in the cell cycle and formation of the mitotic spindle, enabling cells to bypass a G2 arrest upon irradiation and leading to the entry into mitosis despite compromised genome integrity. This results in the formation of abnormal mitotic spindles and a lower proliferation rate. Altogether, the current data uncover a novel signaling mechanism through which the DDR uses a growth factor receptor system for regulating and maintaining genome stability. [GRAPHICS] .
引用
收藏
页码:2113 / 2125
页数:13
相关论文
共 53 条
  • [1] Replication fork instability and the consequences of fork collisions from rereplication
    Alexander, Jessica L.
    Orr-Weaver, Terry L.
    [J]. GENES & DEVELOPMENT, 2016, 30 (20) : 2241 - 2252
  • [2] Randomized Phase III Trial of Concurrent Accelerated Radiation Plus Cisplatin With or Without Cetuximab for Stage III to IV Head and Neck Carcinoma: RTOG 0522
    Ang, K. Kian
    Zhang, Qiang
    Rosenthal, David I.
    Nguyen-Tan, Phuc Felix
    Sherman, Eric J.
    Weber, Randal S.
    Galvin, James M.
    Bonner, James A.
    Harris, Jonathan
    El-Naggar, Adel K.
    Gillison, Maura L.
    Jordan, Richard C.
    Konski, Andre A.
    Thorstad, Wade L.
    Trotti, Andy
    Beitler, Jonathan J.
    Garden, Adam S.
    Spanos, William J.
    Yom, Sue S.
    Axelrod, Rita S.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (27) : 2940 - +
  • [3] Physical interaction between epidermal growth factor receptor and DNA-dependent protein kinase in mammalian cells
    Bandyopadhyay, D
    Mandal, M
    Adam, L
    Mendelsohn, J
    Kumar, R
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (03) : 1568 - 1573
  • [4] Invasive-growth signaling by the Met/HGF receptor -: The hereditary renal carcinoma connection
    Bardelli, A
    Pugliese, L
    Comoglio, PM
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 1997, 1333 (03): : M41 - M51
  • [5] EGFR-targeted anti-cancer drugs in radiotherapy:: Preclinical evaluation of mechanisms
    Baumann, Michael
    Krause, Mechthild
    Dikomey, Ekkehard
    Dittmann, Klaus
    Doerr, Wolfgang
    Kasten-Pisula, Ulla
    Rodemann, H. Peter
    [J]. RADIOTHERAPY AND ONCOLOGY, 2007, 83 (03) : 238 - 248
  • [6] Radiation oncology in the era of precision medicine
    Baumann, Michael
    Krause, Mechthild
    Overgaard, Jens
    Debus, Juergen
    Bentzen, Soren M.
    Daartz, Juliane
    Richter, Christian
    Zips, Daniel
    Bortfeld, Thomas
    [J]. NATURE REVIEWS CANCER, 2016, 16 (04) : 234 - 249
  • [7] Deciphering MET-dependent modulation of global cellular responses to DNA damage by quantitative phosphoproteomics
    Bensimon, Ariel
    Koch, Jonas P.
    Francica, Paola
    Roth, Selina M.
    Riedo, Rahel
    Glueck, Astrid A.
    Orlando, Eleonora
    Blaukat, Andree
    Aebersold, Daniel M.
    Zimmer, Yitzhak
    Aebersold, Ruedi
    Medova, Michaela
    [J]. MOLECULAR ONCOLOGY, 2020, 14 (06) : 1185 - 1206
  • [8] The Met kinase inhibitor SU11274 exhibits a selective inhibition pattern toward different receptor mutated variants
    Berthou, S
    Aebersold, DM
    Schmidt, LS
    Stroka, D
    Heigl, C
    Streit, B
    Stalder, D
    Gruber, G
    Liang, CX
    Howlett, AR
    Candinas, D
    Greiner, RH
    Lipson, KE
    Zimmer, Y
    [J]. ONCOGENE, 2004, 23 (31) : 5387 - 5393
  • [9] Receptor tyrosine kinase signaling in cancer radiotherapy and its targeting for tumor radiosensitization
    Bhattacharya, Poushali
    Shetake, Neena G.
    Pandey, Badri N.
    Kumar, Amit
    [J]. INTERNATIONAL JOURNAL OF RADIATION BIOLOGY, 2018, 94 (07) : 628 - 644
  • [10] Reproducible isolation of distinct, overlapping segments of the phosphoproteome
    Bodenmiller, Bernd
    Mueller, Lukas N.
    Mueller, Markus
    Domon, Bruno
    Aebersold, Ruedi
    [J]. NATURE METHODS, 2007, 4 (03) : 231 - 237